CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $525.28 | $21K | 130 |
| 2026-03-02 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 230,500 | ||
| 2026-02-27 | Olian Judy D. Director | Sale 10b5-1 | −200 | $509.55 | $102K | 4,845 |
| 2026-02-25 | CAUSEY CHRISTOPHER Director | Option exercise 10b5-1 | +1,000 | $119.76 | $120K | 5,190 |
| 2026-02-25 | CAUSEY CHRISTOPHER Director | Sale 10b5-1 | −1,000 | $520.00 | $520K | 4,190 |
| 2026-02-25 | CAUSEY CHRISTOPHER Director | Option exercise · Stock Option 10b5-1 | −1,000 | 6,320 | ||
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +9,375 | $117.76 | $1.1M | 9,375 |
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −9,375 | $472.13 | $4.4M | 0 |
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +5,065 | $146.03 | $740K | 5,065 |
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −5,065 | $472.13 | $2.4M | 0 |
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Common Stock 10b5-1 | −9,375 | 0 | ||
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Common Stock 10b5-1 | −5,065 | 0 | ||
| 2026-02-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 45,081 |
| 2026-02-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −616 | $471.36 | $290K | 44,465 |
| 2026-02-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −775 | $472.76 | $366K | 43,690 |
| 2026-02-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −288 | $473.23 | $136K | 43,402 |
| 2026-02-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,059 | $475.09 | $503K | 42,343 |
| 2026-02-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −881 | $475.89 | $419K | 41,462 |
| 2026-02-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,114 | $477.10 | $531K | 40,348 |
| 2026-02-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,100 | $478.15 | $1.0M | 38,248 |
Page 157 of 171 · 3,408 trades